Press release
Ankylosing Spondylitis Drugs Market Major Drivers and Trends 2023 to 2030 | Top Players as Merck & Co., BoehringerIngelheim
Ankylosing Spondylitis Drugs Market by Molecule Type (Small Molecules, Biologics, Biosimilars), Route of Administration (Parenteral, Oral), Distribution Channel, Regions, and Global Forecast 2021-2028
ππ«ππ ππ‘π π¬ππ¦π©π₯π π«ππ©π¨π«π- https://www.thebrainyinsights.com/enquiry/sample-request/12527
Some of the major companies in the global ankylosing spondylitis drugs market are Johnson & Johnson, Abbvie, Hetero, Merck & Co., BoehringerIngelheim, UCB, Amgen, Janssen Biotech, Inc., ZydusCadila and Izana Bioscience among others. To enhance their market position in the global ankylosing spondylitis drugs market, the key players are now focusing on adopting the strategies such as product innovations, recent developments, mergers & acquisitions, joint venture, collaborations, and partnership. For instance, in January 2019, ZydusCadila announced the launch of its biosimilarAdalimumab, and to be marketed under the brand name Exemptia, to treat autoimmune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, and Ankylosing Spondylitis.
The molecule type segment is divided into small molecules, biologics, and biosimilars. The biologics is anticipated to grow at the highest CAGR of 9.9% over the forecast period. This is attributable to its more promising results in clinical development as compared to other molecules. It helps to reduce the back pain and stiffness by targeting specific proteins in the immune system that cause inflammation, including tumour necrosis factor (TNF) and interleukin 17 (IL17). The route of administration segment includes oral and parental. The oral segment accounted for the major market share of 64.8% in 2020. This is mainly due to, major drugs for these conditions are given by oral route of administration. The distribution channel segment includes hospitals, pharmacy, retail pharmacy, and online pharmacy. Online pharmacy segment is anticipated to grow at the highest CAGR of 10.2% over the forecast period. The rising preference of patient for the online pharmacy due to convenience boosting the market growth.
ACCESS FULL REPORT: https://www.thebrainyinsights.com/report/ankylosing-spondylitis-drugs-market-12527
Increasing incidence of ankylosing spondylitis across the globe, further propelling the growth of ankylosing spondylitis drugs market. In addition to this, an increasing proportion of female patients with ankylosing spondylitis, further fueling the growth of the market. However, adverse side effects of various drugs on the body and limited awareness about ankylosing spondylitis, are some of the key factors hindering the growth of the market.
About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.
Media Contact
Avinash D
Organization: The Brainy Insights
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: www.thebrainyinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ankylosing Spondylitis Drugs Market Major Drivers and Trends 2023 to 2030 | Top Players as Merck & Co., BoehringerIngelheim here
News-ID: 3143537 • Views: β¦
More Releases from The Brainy Insights
Generative AI Market : Transforming the Future of Human Creativity and Productiv β¦
Generative AI Market : Transforming the Future of Human Creativity and Productivity
Introduction
The global Generative AI market is expected to grow from USD 11.77 billion in 2023 to USD 256.72 billion by 2033, at a CAGR of 36.10% during the forecast period 2024-2033.
In recent years, Generative AI has moved from science fiction to the center of digital innovation. From crafting human-like text to generating artwork, music, code, and even realistic videos,β¦
The Future of Generative AI: Growth, Innovation, and Market Projections
The generative AI market is experiencing rapid growth, driven by technological advancements and increasing adoption across various industries. Here's an overview of the market, including recent developments, drivers, restraints, regional segmentation, emerging trends, top use cases, major challenges, and attractive opportunities.
https://www.thebrainyinsights.com/report/generative-ai-market-13297
The global Generative AI market is expected to grow from USD 11.77 billion in 2023 to USD 256.72 billion by 2033, at a CAGR of 36.10% during the forecast periodβ¦
Regtech Industry Forecasted to Reach $99.28 Billion by 2033
The Brainy Insights estimates that the USD 12.92 billion in 2023 global Regtech market will reach USD 99.28 billion by 2033. With the help of Regtech Solutions, the financial sector has remained a primary focus. Yet, a new expanding trend is associated with the non-financial sphere, including healthcare and pharmaceuticals, energy and telecommunication industries. Increased regulatory demands in these industries also promise to provide opportunities for Regtech vendors to produceβ¦
Camping Tent Market Key Companies Growth by 2032 - Boffi, Scavolini S.P.A, Tuppe β¦
Global Camping Tent market report is a well-conceived and accurately delivered market intelligence report depicting crucial elements across the current and historic market states that play a crucial role in influencing unfaltering forecast and predictions in the Camping Tent market.
The report is so designed to address the crucial facets of the market such as market dimensions and size, market trends, investment strategies, pricing structure and driver specific analytical review thatβ¦
More Releases for Ankylosing
Ankylosing Spondylitis Medication Market Size And Global Industry Forecast 2034
"As of 2024, the global ankylosing spondylitis (AS) medication market is valued at approximately $5 billion, driven by an increasing prevalence of the condition and a growing awareness of treatment options. The market is projected to reach roughly $9 billion by 2034, reflecting a robust growth trajectory over the next decade. The anticipated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at aroundβ¦
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World β¦
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate?
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.β¦
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
ππ¨π°π§π₯π¨ππ πππ¦π©π₯π πππ©π¨π«π: https://www.alliedmarketresearch.com/request-sample/2638
Introduction:
The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively.
Unveiling Ankylosingβ¦
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.β¦
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate theβ¦
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, βAnkylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020β2027.β According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgenβ¦
